X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. VENUS REMEDIES FDC LTD./
VENUS REMEDIES
 
P/E (TTM) x 17.7 -5.4 - View Chart
P/BV x 4.0 0.2 1,999.8% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 FDC LTD.   VENUS REMEDIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
VENUS REMEDIES
Mar-18
FDC LTD./
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs144126 114.0%   
Low Rs7961 129.3%   
Sales per share (Unadj.) Rs47.6301.8 15.8%  
Earnings per share (Unadj.) Rs7.6-24.9 -30.6%  
Cash flow per share (Unadj.) Rs9.02.5 354.1%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5293.3 16.2%  
Shares outstanding (eoy) m177.8312.34 1,441.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.3 754.9%   
Avg P/E ratio x14.6-3.8 -388.9%  
P/CF ratio (eoy) x12.336.7 33.6%  
Price / Book Value ratio x2.30.3 734.1%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7841,154 1,714.7%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m1,221393 310.5%   
Avg. sales/employee Rs ThNM4,026.1-  
Avg. wages/employee Rs ThNM425.0-  
Avg. net profit/employee Rs ThNM-331.8-  
INCOME DATA
Net Sales Rs m8,4593,724 227.1%  
Other income Rs m39423 1,749.1%   
Total revenues Rs m8,8523,747 236.3%   
Gross profit Rs m2,070395 524.4%  
Depreciation Rs m249338 73.6%   
Interest Rs m31354 8.8%   
Profit before tax Rs m2,184-275 -793.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60632 1,916.3%   
Profit after tax Rs m1,353-307 -440.9%  
Gross profit margin %24.510.6 230.9%  
Effective tax rate %27.7-11.5 -241.6%   
Net profit margin %16.0-8.2 -194.1%  
BALANCE SHEET DATA
Current assets Rs m4,3552,638 165.1%   
Current liabilities Rs m1,7922,305 77.8%   
Net working cap to sales %30.38.9 338.9%  
Current ratio x2.41.1 212.4%  
Inventory Days Days44135 32.8%  
Debtors Days Days2546 53.2%  
Net fixed assets Rs m3,0254,871 62.1%   
Share capital Rs m179123 144.7%   
"Free" reserves Rs m8,2433,496 235.8%   
Net worth Rs m8,4533,619 233.6%   
Long term debt Rs m111,374 0.8%   
Total assets Rs m10,5577,509 140.6%  
Interest coverage x71.40.2 32,028.7%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.80.5 161.5%   
Return on assets %13.10.6 2,076.9%  
Return on equity %16.0-8.5 -188.8%  
Return on capital %23.51.6 1,486.0%  
Exports to sales %13.30-   
Imports to sales %3.313.9 24.1%   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283517 54.7%   
Fx inflow Rs m1,1460-   
Fx outflow Rs m355517 68.8%   
Net fx Rs m791-517 -153.1%   
CASH FLOW
From Operations Rs m1,485514 288.7%  
From Investments Rs m-620-123 503.2%  
From Financial Activity Rs m-753-387 194.4%  
Net Cashflow Rs m1134 2,685.7%  

Share Holding

Indian Promoters % 68.9 32.9 209.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.2 2,611.1%  
FIIs % 7.5 0.6 1,293.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 66.4 28.6%  
Shareholders   23,730 20,121 117.9%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   SUN PHARMA  MERCK LTD  NOVARTIS  J.B.CHEMICALS  DR. REDDYS LAB  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (1QFY19); Net Profit Down 756.1% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, VENUS REMEDIES has posted a net profit of Rs 56 m (down 756.1% YoY). Sales on the other hand came in at Rs 655 m (down 16.2% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Nov 20, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS